Early research (Phase 1)WithdrawnNCT01320787What this trial is testing18-F-Fluoroacetate as PET Imaging AgentWho this might be right forBrain CancerBreast CancerProstate Cancer M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04585750What this trial is testingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Who this might be right forAdvanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)UnknownNCT03666325What this trial is testingImmunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary ResistanceWho this might be right forSkin Neoplasm Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 43
Large-scale testing (Phase 3)UnknownNCT02404051What this trial is testingFulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerWho this might be right forMetastatic Breast CancerBreast CancerHormone Receptor Positive Tumor+2 more Consorzio Oncotech 745
Testing effectiveness (Phase 2)Study completedNCT02614794What this trial is testingTucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerWho this might be right forHER2 Positive Breast Cancer Seagen Inc. 612
Testing effectiveness (Phase 2)Looking for participantsNCT04550494What this trial is testingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Testing effectiveness (Phase 2)Looking for participantsNCT06265285What this trial is testingComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramWho this might be right forAdvanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more Mayo Clinic 50
Early research (Phase 1)Study completedNCT01325558What this trial is testingALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Malignant NeoplasmMalignant Solid Tumour Altor BioScience 30
Early research (Phase 1)UnknownNCT03903458What this trial is testingTinostamustine and Nivolumab in Advanced MelanomaWho this might be right forMalignant Melanoma Markus Joerger 21
Testing effectiveness (Phase 2)Ended earlyNCT05714553What this trial is testingNUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursWho this might be right forAdvanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more NuCana plc 19
Early research (Phase 1)Study completedNCT02227082What this trial is testingOlaparib and Radiotherapy in Inoperable Breast CancerWho this might be right forLocally Advanced Malignant NeoplasmInflammatory Breast CarcinomaTriple-Negative Invasive Breast Carcinoma The Netherlands Cancer Institute 7
Early research (Phase 1)Ended earlyNCT03878524What this trial is testingSerial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAnatomic Stage IV Breast Cancer AJCC v8Anemia+47 more OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Ended earlyNCT01586195What this trial is testingStudy Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600EWho this might be right forMalignant Melanoma Genentech, Inc. 31
Testing effectiveness (Phase 2)Looking for participantsNCT07280832What this trial is testingPhase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant MelanomaWho this might be right forUnresectable Locally Advanced or Metastatic Melanoma Shanghai JMT-Bio Inc. 188
Testing effectiveness (Phase 2)Study completedNCT01693068What this trial is testingPhase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous MelanomaWho this might be right forN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma EMD Serono 194
Early research (Phase 1)Active Not RecruitingNCT05311397What this trial is testingA166 in Patients With Advanced Solid Malignant TumorsWho this might be right forBreast Cancer Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07287995What this trial is testingASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsWho this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 428
Testing effectiveness (Phase 2)Ended earlyNCT03601897What this trial is testingA Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor Deciphera Pharmaceuticals, LLC 177
Testing effectiveness (Phase 2)Looking for participantsNCT06362369What this trial is testingOral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyWho this might be right forAdvanced CancerAdvanced Solid TumorMelanoma+15 more 7 Hills Pharma, LLC 126